Literature DB >> 2056407

Outcome of hydronephrosis diagnosed antenatally.

B Kletscher1, F de Badiola, R Gonzalez.   

Abstract

We evaluated 23 neonates with prenatally diagnosed dilatation of the renal pelvis involving 33 renal units. The dilatation was graded from 0 to 4 by ultrasonography. Diuresis renography was used to evaluate differential renal function. The patterns of the excretory curve following administration of furosemide were analyzed. Antegrade pyelography and pressure flow studies were done in selected patients. The mean follow-up was 34 weeks. The single most important prognostic indicator in this group of patients was the degree of dilatation on ultrasonography. Six of 7 renal units with grade I hydronephrosis improved and 1 remained stable on follow-up. Four of the 12 renal units with grade II hydronephrosis improved spontaneously; 1 remained stable. Three of 11 renal units with grade III hydronephrosis either improved or remained stable. The measurement of differential renal functions on DTPA renography did not correlate well with the degree of dilatation when renal size and parenchymal thickness were adequate. The excretory curves after lasix administration were not helpful to determine treatment in the neonatal period. Seventeen renal units (7 grade II, 9 grade III, 1 grade IV) were treated surgically due to persistent dilatation, evidence of obstruction on either DTPA renography or the Whitaker test, or because of impaired renal function. Sixteen of the 33 renal units diagnosed prenatally improved with observation. Of all the parameters studied only the degree of dilatation on ultrasonography correlated well with the prognosis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056407     DOI: 10.1016/0022-3468(91)90995-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

Review 1.  Outcome of isolated antenatal hydronephrosis: a systematic review and meta-analysis.

Authors:  Gagan Sidhu; Joseph Beyene; Norman D Rosenblum
Journal:  Pediatr Nephrol       Date:  2005-12-17       Impact factor: 3.714

2.  In support of early surgical repair of ureteropelvic junction obstruction.

Authors:  R V Pieretti; S Marcano; R V Pieretti-Vanmarcke
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

3.  Non-intubated pyeloplasty for pelviureteric junction obstruction in children.

Authors:  S Ahmed; S Crankson
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

4.  Outcome of patients with antenatally detected pelviureteric junction obstruction.

Authors:  Elisa Ylinen; Marja Ala-Houhala; Sakari Wikström
Journal:  Pediatr Nephrol       Date:  2004-05-18       Impact factor: 3.714

5.  Correlation of ultrasound and renal scintigraphy in children with unilateral hydronephrosis in primary workup.

Authors:  E U Nitzsche; L B Zimmerhackl; R A Hawkins; B Stöver; A Frankenschmidt; G Sigmund; Y Choi; C K Hoh; E A Moser
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

6.  Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology.

Authors:  S K Fernbach; M Maizels; J J Conway
Journal:  Pediatr Radiol       Date:  1993

7.  Clinical importance of pyelocalyceal dilation diagnosed by postnatal ultrasonographic screening of the urinary tract.

Authors:  Kristina Drnasin; Mirna Saraga-Babić; Marijan Saraga
Journal:  Med Sci Monit       Date:  2013-02-19

8.  Comparative study of different surgical approaches for treatment of UPJ obstruction according to the degree/severity of hydronephrosis factor.

Authors:  Peng Zhao; Cao Wang; Kaiyi Mao; Zhen Luo; Yingbo Li; Guangxu Zhou; Hongyang Tan; Hong Liu; Yucheng Mao; Hong Ma; Xianhui Shang; Bin Liu
Journal:  Front Pediatr       Date:  2022-08-04       Impact factor: 3.569

9.  The BULT Method for Pediatric Minilaparoscopic Pyeloplasty in Infants: Technique and Results.

Authors:  Barbara Magda Ludwikowski; Michael Botländer; Ricardo González
Journal:  Front Pediatr       Date:  2016-05-25       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.